Cellphire
Rockville, MD, United StatesFounded 2005Industry
Cellphire develops freeze-dried platelet products funded for radiation-related injury. CBRNE-relevant work is a notable product line according to its website. It is headquartered in Rockville, MD, United States.
What it does
Threats covered
Profile
Cellphire, now Cellphire Therapeutics, is a Rockville, Maryland biotechnology company developing platelet-derived therapies, including Thrombosomes, a freeze-dried hemostatic product. It was founded around 2005 or early 2006 and rebranded in 2021.
More profile
The Biomedical Advanced Research and Development Authority contracted with it in 2013 for a multi-year programme valued at up to 82.6 million dollars, and exercised a third option worth 33.3 million dollars in 2020. Its disclosed private funding includes a 15 million dollar Series A in 2021 and 5 million dollars of debt financing in 2023 and again in 2025.
The state of Maryland also announced 1 million dollars in InvestMaryland funding.
Ownership
Privately held; venture-backed; 15 million dollar Series A in 2021 led by Simcah Management and debt financing in 2023 and 2025
Parent: none identified
Sources (5)
- https://commerce.maryland.gov/media/Pages/PressReleases/Biotech-Company-Cellphire-Tapped-for-$1-million-in-InvestMaryland-Funding-.aspx
- https://pitchbook.com/profiles/company/63869-05
- https://www.cellphire.com/news/cellphire-inc-announces-rebrand-to-cellphire-therapeutics-inc
- https://www.cellphire.com/news/cellphire-announces-exercise-by-barda-of-option-3-of-contract-to-develop-platelet-based-hemostatic
- https://www.cellphire.com/news/cellphire-closes-15-million-series-a-funding-round-led-by-simcah-management
Not verified or not found
- Exact founding date: 2005 or early 2006.
- The link between the BARDA programme and acute radiation syndrome was not read in the contract text and rests on the sheet and general descriptions.
- Funding after 2025: not found.
Questions
What does Cellphire do?
Cellphire develops freeze-dried platelet products funded for radiation-related injury. CBRNE-relevant work is a notable product line according to its website.
Where is Cellphire based?
HQ (as found): Rockville, MD. HQ country: US.
Who owns Cellphire?
Privately held; venture-backed; 15 million dollar Series A in 2021 led by Simcah Management and debt financing in 2023 and 2025. Parent: none identified
Profiles are compiled from public sources and sampled-checked, not fully audited. Last verified 17 October 2026. Report a correction